Diabetes Mellitus, Type 2: all 9,590 studies
Page 21 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Study of Ertugliflozin in Healthy Male Participants (MK-8835-020)CompletedNCT02411929Phase 1Results posted
- Improving Medication Adherence Among Underserved Patients With Type 2 DiabetesCompletedNCT02409329Not applicableResults posted
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT02408120Phase 4Results posted
- The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium ExcretionCompletedNCT02406443Phase 4Results posted
- Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin SecretionCompletedNCT02397447Phase 2Results posted
- A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusCompletedNCT02390050Phase 2Results posted
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01TerminatedNCT02377362Phase 1Results posted
- Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 DiabetesTerminatedNCT02373865Phase 4Results posted
- The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes SubjectsCompletedNCT02372630Phase 4Results posted
- Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2CompletedNCT02371759Phase 3Results posted
- A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEICompletedNCT02370537Phase 2Results posted
- Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabetes MellitusCompletedNCT02367131Results posted
- A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02367066Phase 1Results posted
- Fatty Liver Study in Patients With Type II DiabetesTerminatedNCT02365233Phase 4Results posted
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)CompletedNCT02354235Phase 3Results posted
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)CompletedNCT02354222Phase 3Results posted
- A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCompletedNCT02332824Phase 2Results posted
- ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLDCompletedNCT02330549Phase 2Results posted
- Pilot Test of a Chinese Menu Plan for Type 2 DiabetesCompletedNCT02327429Not applicableResults posted
- Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 DiabetesCompletedNCT02325466Phase 3Results posted
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic PatientsCompletedNCT02324842Not applicableResults posted
- A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT02324569Phase 3Results posted
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsCompletedNCT02320721Phase 3Results posted
- REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-DiabetesCompletedNCT02320253Not applicableResults posted
- Optimizing Behavioral Health Homes for Adults With Serious Mental IllnessCompletedNCT02318797Not applicableResults posted
- Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)CompletedNCT02318693Phase 4Results posted
- Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic PatientsCompletedNCT02314637Phase 3Results posted
- Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 DiabetesCompletedNCT02312063Phase 4Results posted
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT02305381Phase 3Results posted
- Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes MellitusTerminatedNCT02303405Phase 2Results posted
- A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes MellitusCompletedNCT02302716Phase 3Results posted
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot StudyCompletedNCT02299388Phase 4Results posted
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyCompletedNCT02299050Phase 4Results posted
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsCompletedNCT02298192Phase 3Results posted
- Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineCompletedNCT02294474Phase 3Results posted
- A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As MonotherapyCompletedNCT02292433Phase 1Results posted
- The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control StudyCompletedNCT02290925Phase 3Results posted
- PilAm Go4Health Weight Loss Program to Prevent Heart DiseaseCompletedNCT02290184Not applicableResults posted
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.CompletedNCT02288273Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy AloneCompletedNCT02284893Phase 3Results posted
- Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsCompletedNCT02283411Not applicableResults posted
- Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlCompletedNCT02273050Phase 3Results posted
- The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 DiabetesCompletedNCT02269098Not applicableResults posted
- Physical Activity and ParticipationCompletedNCT02268916Not applicableResults posted
- A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American IndiansCompletedNCT02266576Not applicableResults posted
- Sitagliptin and Glucagon CounterregulationCompletedNCT02256189Phase 4Results posted
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 DiabetesCompletedNCT02254291Phase 3Results posted
- Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 DiabetesCompletedNCT02252965Phase 4Results posted
- Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal SyndromeCompletedNCT02251431Phase 3Results posted
- The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 DiabetesCompletedNCT02248714Not applicableResults posted
- Adult Accuracy Study of the Enlite 3 Glucose SensorCompletedNCT02246582Not applicableResults posted
- 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin MonotherapyCompletedNCT02243176Phase 4Results posted
- Linagliptin as Add on to Basal Insulin in the ElderlyCompletedNCT02240680Phase 4Results posted
- Dapagliflozin Effects on Epicardial FatCompletedNCT02235298Phase 4Results posted
- Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusCompletedNCT02229227Phase 3Results posted
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)CompletedNCT02227875Phase 3Results posted
- Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes MellitusCompletedNCT02227849Phase 4Results posted
- Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)CompletedNCT02226003Phase 3Results posted
- Vascular Lifestyle-Intervention and Screening in PharmacyStatus unknownNCT02223793Not applicableResults posted
- Bioequivalence Study Coadministered to Healthy Subjects in the Fasted StateCompletedNCT02223065Phase 1Results posted
- Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"CompletedNCT02221284Results posted
- Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT02220920Phase 4Results posted
- Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 DiabetesCompletedNCT02220907Phase 3Results posted
- Telemedicine Strategy With Home Treatment Save ResourcesCompletedNCT02214017Not applicableResults posted
- A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes MellitusCompletedNCT02211261Phase 1Results posted
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 DiabetesCompletedNCT02207374Phase 3Results posted
- Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus.CompletedNCT02206607Phase 1Results posted
- A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes PatientsCompletedNCT02202161Phase 2Results posted
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 DiabeticsCompletedNCT02197520Phase 1Results posted
- Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of LinagliptinCompletedNCT02197078Results posted
- Feasibility Study of DermGEN for Diabetic Foot Ulcer TreatmentCompletedNCT02184455Phase 1Results posted
- 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and HypertensionCompletedNCT02182830Phase 3Results posted
- Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>CompletedNCT02181842Results posted
- Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 DiabetesCompletedNCT02180646Not applicableResults posted
- Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes MellitusCompletedNCT02175121Phase 2Results posted
- Improving Medication Adherence in Older African Americans With DiabetesCompletedNCT02174562Not applicableResults posted
- Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal InsulinCompletedNCT02168491Phase 3Results posted
- Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.CompletedNCT02157298Phase 4Results posted
- Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes MellitusCompletedNCT02154347Phase 4Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesCompletedNCT02152371Phase 3Results posted
- Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic PatientsCompletedNCT02151461Phase 2Results posted
- PK/PD Study of U-500 Regular InsulinCompletedNCT02148250Phase 2Results posted
- Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic TherapyCompletedNCT02140645Results posted
- Oral and Non-insulin Injected Hypoglycemic Therapy Utilization PatternsCompletedNCT02138097Results posted
- A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 DiabetesCompletedNCT02132637Phase 3Results posted
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTerminatedNCT02131272Phase 3Results posted
- Effect of Chronic ACE and DPP4 Inhibition on Blood PressureCompletedNCT02130687Not applicableResults posted
- Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 DiabetesTerminatedNCT02130401Not applicableResults posted
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesCompletedNCT02128932Phase 3Results posted
- Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes MellitusCompletedNCT02121483Phase 1Results posted
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 DiabetesCompletedNCT02119819Phase 2Results posted
- Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)CompletedNCT02115347Phase 1Results posted
- A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging CommunityCompletedNCT02114814Not applicableResults posted
- A Study of LY2409021 in Participants With Type 2 Diabetes MellitusTerminatedNCT02111096Phase 2Results posted
- Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and DiabetesCompletedNCT02107976Not applicableResults posted
- Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlCompletedNCT02104804Phase 3Results posted
- A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further IntensificationCompletedNCT02100475Phase 3Results posted
- Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic PatientsCompletedNCT02099838Phase 4Results posted
- Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)CompletedNCT02099110Phase 3Results posted
- Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to PioglitazoneCompletedNCT02098746Results posted